BioMimetic Therapeutics, Inc. Achieves Patient Enrollment Target (396) in North American Pivotal Study for Augment™ Bone Graft
Dec. 11, 2008
|
|
|
BioMimetic Therapeutics, Inc. Announces Patent Allowance from the United States Patent and Trademark Office for PDGF Compositions Patent; Expanded protection for Augment™, Augment™ Injectable and GEM 21S® until 2024
Nov. 21, 2008
|
|
|
BioMimetic Therapeutics Ranked 181 Fastest Growing Company in North America on Deloitte's 2008 Technology Fast 500
Nov. 13, 2008
|
|
|
BioMimetic Therapeutics Reports 2008 Third Quarter Results
Nov. 11, 2008
|
|
|
BioMimetic Therapeutics to Report 2008 Third Quarter Financial Results on November 10
Nov. 6, 2008
|
|
|
BioMimetic Therapeutics Reports Promising Clinical Results Using Augment Injectable Bone Graft to Treat Distal Radius Fractures; Enrollment in North American Augment Pivotal Trial Accelerates; 314 of 396 Patients Enrolled
Nov. 3, 2008
|
|
|
BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at the BIO Investor Forum
Oct. 28, 2008
|
|
|
BioMimetic Therapeutics Adds $39 Million of Liquidity; Reaches Agreement with Deutsche Bank to Provide Credit Facility using Auction-Rate Securities as Collateral
Oct. 28, 2008
|
|
|
BioMimetic Therapeutics Announces No Changes Requested by Independent Data Monitoring Committee to Pivotal Trial Design for Augment™ Bone Graft; 268 of 396 Patients Enrolled to Date in U.S. Pivotal Trial
Sep. 23, 2008
|
|
|
BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at the UBS Global Life Sciences Conference
Sep. 22, 2008
|
|
|
BioMimetic Therapeutics Reports 2008 Second Quarter Results; Positive Results Achieved with Augment™ Injectable Bone Graft to Enhance Healing in Foot and Ankle Fusions
Aug. 12, 2008
|
|
|
BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at the Canaccord Adams Global Growth Conference
Aug. 8, 2008
|
|
|
BioMimetic Therapeutics to Report 2008 Second Quarter Financial Results on August 11; Company to Release Results of Augment Injectable Bone Graft in Foot and Ankle Fusions
Aug. 6, 2008
|
|
|
BioMimetic Therapeutics Launches Augment™ as the New Brand Name for the Company's Orthopedic Product Line; Clinical Investigator to Present Canadian Trial Results at AOFAS Meeting
June 24, 2008
|
|
|
BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at the Jefferies 2nd Annual Healthcare Conference
June 20, 2008
|
|
|
BioMimetic Therapeutics Announces Highlights from Annual Meeting of Stockholders
June 12, 2008
|
|
|
BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at Bank of America Securities 2008 Healthcare Conference
May 13, 2008
|
|
|
BioMimetic Therapeutics Releases First Quarter Earnings Results; $33.4 Million Cash Received from the Sale of Orofacial Therapeutic Business
May 8, 2008
|
|
|
BioMimetic Therapeutics to Report 2008 First Quarter Financial Results on May 8
May 7, 2008
|
|
|
BioMimetic Therapeutics Receives Written Communication from FDA Confirming Status of Ongoing Pivotal Trial for GEM OS1; No Changes Recommended to Trial Design
April 21, 2008
|
|
|
BioMimetic Therapeutics Addresses FDA Communication on Regranex Safety Review
March 27, 2008
|
|
|
BioMimetic Therapeutics Reports 2007 Fourth Quarter and Year-end Results; Year Marked by Strong Cash Position, Positive Orthopedic Data and Progressing Clinical Trials
March 12, 2008
|
|
|
BioMimetic Therapeutics, Inc. Provides Updates on Clinical and Preclinical Activities; Company Receives Go Ahead from Health Canada to File GEM OS1 DLA
March 7, 2008
|
|
|
BioMimetic Therapeutics, Inc. to Highlight Clinical and Preclinical Activities at ORS and AAOS Meetings
Feb. 29, 2008
|
|
|
BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at Deutsche Bank Small and Mid Cap Growth Conference
Feb. 14, 2008
|
|
|
BioMimetic Therapeutics, Inc. to Present at BIO CEO and Investor Conference
Feb. 8, 2008
|
|
|
BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at Wachovia Healthcare Research Conference
Jan. 29, 2008
|
|
|
BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at the Stanford Group Company Annual Healthcare Conference
Jan. 15, 2008
|
|
|
BioMimetic Therapeutics Closes on Transaction to Sell Remaining Dental Business
Jan. 7, 2008
|
|
|
